Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data.
about
Drug-resistant tuberculosis in Eastern Europe: challenges and ways forwardTargeting Mycobacterium tuberculosis nucleoid-associated protein HU with structure-based inhibitorsInfection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the KeyHospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort StudyCOUNTING THE MISSING CASES: ESTIMATING THE GLOBAL BURDEN OF MULTIDRUG-RESISTANT TUBERCULOSIS AMONG PREVALENT CASES OF TBMDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisHigh pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.Understanding pharmacokinetics to improve tuberculosis treatment outcome.On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimatesBeyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.Multidrug-resistant tuberculosis around the world: what progress has been made?Imported bugs, not beasts: extensively drug-resistant tuberculosis and acute kidney injury.Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam.MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why?The Non-Essential Mycolic Acid Biosynthesis Genes hadA and hadC Contribute to the Physiology and Fitness of Mycobacterium smegmatisThe Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, RussiaDoes Alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, IndiaEvolution of Mycolic Acid Biosynthesis Genes and Their Regulation during Starvation in Mycobacterium tuberculosis.The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general populationScreening difficult-to-reach populations for tuberculosis using a mobile medical unit, Punjab India.Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infectionRisk Factors for Primary Pulmonary TB in Almaty Region, Kazakhstan: A Matched Case-Control StudyClinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China: A Cross-sectional StudySafety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies.Population aging and migrant workers: bottlenecks in tuberculosis control in rural China.Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.Evidence to inform resource allocation for tuberculosis control in Myanmar: a systematic review based on the SYSRA framework.Limited access to drugs for resistant tuberculosis: a call to action.Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.Transmission modeling and health systems: the case of TB in India.Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009-2013.Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection.Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.IP-10 Kinetics in the First Week of Therapy are Strongly Associated with Bacteriological Confirmation of Tuberculosis Diagnosis in HIV-Infected Patients.
P2860
Q26782448-9557630C-60BB-4770-983D-20375456A9A9Q27690716-62144B4C-3B65-4928-A12E-3BA4A05060A2Q28393098-CED36E6E-485B-46D0-80BD-E265F5D0AB63Q28397917-615734BD-3DA0-4A9A-B1F9-8F6104CD5D5EQ28546611-431E2F09-9A30-4753-B349-DA921C2420BCQ29247876-2A35A01D-7013-4FED-9657-66E752216CE5Q29247878-19FB5A1F-96C8-4396-BEAE-BDE455C73B46Q30377730-43244D93-53CE-43D1-BFF4-BB866DCA4BC8Q30411703-42EFCC76-EDCB-49E9-B20D-A675D61F77A4Q30873423-A7874225-DA15-4872-858B-35E1DF9271A0Q33889335-E8A8668C-C624-4947-B75B-46740E874BC5Q34226104-4CA61411-8034-4E70-A1E3-C9767C21E4E1Q35054224-028B8F20-0FC3-438C-B6B5-629B54A9EEFBQ35310567-0779A9E3-40C0-4A4A-82B6-447ABFB1A14DQ35673425-EAFF063B-0BB9-4C23-B403-CFC89E31DA91Q35790838-1CA70E1F-C31D-4454-B1AD-0F12938634DFQ35805002-DC11B6E0-32AB-4F65-B759-DBDE51CA702AQ35877895-1BCDEB7B-0309-42DC-ADE4-A522D704197CQ36094198-55C706EA-05FA-43A0-AAC9-3B6A7DB5AE62Q36106172-0416D6D5-B575-41FC-ACF6-4B07B12C9833Q36212134-293620E8-5D34-4F5A-96F1-03A3B35B493CQ36244615-B6584BFF-5E0D-4CAC-B8D9-E400BB5A34DBQ36297481-8E823626-A609-44C2-BA58-8B5290A94C4AQ36302252-308A3F09-8E98-45A9-A060-6AD611C094FEQ36380613-02574C4B-81A1-42F5-AD61-D4CBFF958AC5Q36676017-44E042FB-8A99-480F-8FBD-F7E795BA1D57Q36954429-7D883D6B-D2BB-42EC-B19D-8ED9368941D4Q36993390-19B2F561-ADD2-44AD-BC6E-11AEA0706AD4Q37516784-9B0D855F-25E2-49C2-BDF5-6E00EC0FF637Q37549372-E348D195-62CA-44C9-B6A4-268F870762DCQ38868135-AAE7891E-0557-4DA5-ACE8-23C610F0E52DQ38874012-6ECC6A42-88E2-40F5-99D6-34A362805E76Q38927862-764969CE-82B6-450D-AF03-7562FBE6917CQ39033548-5D32A098-AFBB-422E-9820-E7B54ACCB755Q39033636-24422B48-703D-46C6-88A3-81525FF8AA0EQ40072518-A80F0896-C756-42A6-969F-11074D937800Q41747286-44328742-41FA-4C59-96ED-9E1E2E77CD46Q42715629-0A262725-0E95-4F8B-AFB2-046A345464CAQ47129902-CB4F9ABD-20FB-4E53-9B88-92F8E4176397
P2860
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Universal access to care for m ...... analysis of surveillance data.
@ast
Universal access to care for m ...... analysis of surveillance data.
@en
type
label
Universal access to care for m ...... analysis of surveillance data.
@ast
Universal access to care for m ...... analysis of surveillance data.
@en
prefLabel
Universal access to care for m ...... analysis of surveillance data.
@ast
Universal access to care for m ...... analysis of surveillance data.
@en
P2093
P921
P1476
Universal access to care for m ...... analysis of surveillance data.
@en
P2093
Dennis Falzon
Ernesto Jaramillo
Fraser Wares
Katherine Floyd
Matteo Zignol
P304
P356
10.1016/S1473-3099(13)70130-0
P577
2013-06-04T00:00:00Z